mlsanityData to 14 Oct 2026

DrugMCTS: a drug repurposing framework combining multi-agent, RAG and Monte Carlo Tree Search

arXiv 2507.07426 ↗First posted 10 Jul 2025cs.AI cs.CEcited by 3

On the map: LLM agents and tool use → Medical and scientific domain agents

Abstract (arXiv)

Recent advances in large language models have demonstrated considerable potential in scientific domains such as drug repositioning. However, their effectiveness remains constrained when reasoning extends beyond the knowledge acquired during pretraining. Conventional approaches, such as fine-tuning or retrieval-augmented generation, face limitations in either imposing high computational overhead or failing to fully exploit structured scientific data. To overcome these challenges, we propose DrugMCTS, a novel framework that synergistically integrates RAG, multi-agent collaboration, and Monte Carlo Tree Search for drug repositioning. The framework employs five specialized agents tasked with retrieving and analyzing molecular and protein information, thereby enabling structured and iterative reasoning. Extensive experiments on the DrugBank and KIBA datasets demonstrate that DrugMCTS achieves substantially higher recall and robustness compared to both general-purpose LLMs and deep learning baselines. Our results highlight the importance of structured reasoning, agent-based collaboration, and feedback-driven search mechanisms in advancing LLM applications for drug repositioning.

Key facts. Cited by 3 papers in the map (data through 14 Oct 2026). Placed in Medical and scientific domain agents, one of 16 directions in LLM agents and tool use. Builds on 16 of its 45 references that are in the map. First posted on arXiv 10 Jul 2025.

Builds on

16 of 45 references.

Closest ancestors · 3

Same direction, newest first

  1. 2025LLM Agent Swarm for Hypothesis-Driven Drug Discovery24 Apr
  2. 2025RAG-Enhanced Collaborative LLM Agents for Drug Discovery22 Feb
  3. 2024DrugAgent: Automating AI-aided Drug Discovery Programming through LLM Multi-Agent Collaboration24 Nov

Other references · 13

  1. 2022Self-Consistency Improves Chain of Thought Reasoning in Language Modelscited by 5,708
  2. 2024GPT-4o System Cardcited by 4,588
  3. 2023Lost in the Middle: How Language Models Use Long Contextscited by 3,455
  4. 2024Qwen2 Technical Reportcited by 2,120
  5. 2020ChemBERTa: Large-Scale Self-Supervised Pretraining for Molecular Property Predictioncited by 337
  6. 2019Toward Understanding Catastrophic Forgetting in Continual Learningcited by 68
  7. 2023DrugAssist: A Large Language Model for Molecule Optimizationcited by 59
  8. 2018DeepConv-DTI: Prediction of drug-target interactions via deep learning with convolution on protein sequencescited by 46
  9. 2025Improving Retrieval-Augmented Generation through Multi-Agent Reinforcement Learningcited by 39
  10. 2025Alpha-SQL: Zero-Shot Text-to-SQL using Monte Carlo Tree Searchcited by 34
  11. 2024Large Language Models in Drug Discovery and Development: From Disease Mechanisms to Clinical Trialscited by 24
  12. 2025Does RAG Really Perform Bad For Long-Context Processing?cited by 4
1 more
  1. 2024MolCap-Arena: A Comprehensive Captioning Benchmark on Language-Enhanced Molecular Property Predictioncited by 3

Built on by

Cited by year (2026 to 14 Oct)

Citing papers per year: 2025: 1; 2026: 2.

3 papers.

Similar, not cited

Close in wording, no citation either way

  1. 2025Large Language Model Agent for Modular Task Execution in Drug Discovery
  2. 2025DrugPilot: LLM-based Parameterized Reasoning Agent for Drug Discovery
  3. 2026LLM-Guided Monte Carlo Tree Search over Knowledge Graphs: Composing Mechanistic Explanations for Drug-Disease Pairs
  4. 2026DrugR: Optimizing Molecular Drugs through LLM-based Explicit Reasoning
  5. 2025Exploring Modularity of Agentic Systems for Drug Discovery
  6. 2026DrugPlayGround: Benchmarking Large Language Models and Embeddings for Drug Discovery
  7. 2026M3OS: A Monte Carlo Graph Search-Orchestrated Multi-Agent LLM System for Evidence-Traced Molecular Optimization
  8. 2025RareAgent: Self-Evolving Reasoning for Drug Repurposing in Rare Diseases